Lower serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression

Physiological Research

Volumn 59, Issue 1, 2010, Pages 121-126

  Podlipny J ^a   Hess, Z ^a   Vrzalova J ^a   Rosolova H ^b   Beran, J ^a   Petrlova B ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytokines; Depression; Inflammation; Psychoneuroimmunology

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; IMMUNOLOGY; MALE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; REGRESSION ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952294097     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BARRETT J, HURST MW, DISCALA C, ROSE RM: Prevalence of depression over a 12-month period in a nonpatient population. Arch Gen Psychiatry 35: 741-744, 1978.
2. BERK M, WADEE AA, KUSCHKE RH, ÓNEILL-KERR A: Acute phase proteins in major depression. J Psychosom Res 43: 529-534, 1997.
3. BIGGS JT, WYLIE LT, ZIEGLER VE: Validity of the Zung self-rating depression scale. Br J Psychiat 132: 381-385, 1978.
4. BRAMBILLA F, MAGGIONI M: Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 97: 309-313, 1998.
5. DANTZER R: Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15: 7-24, 2001
6. HAACK M, HINZE-SELCH D, FENZEL T, KRAUS T, KÜHN M, SCHULD A, POLLMÄCHER T: Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33: 407-418, 1999.
7. KAGAYA A, KUGAYA A, TAKEBAYASHI M, FUKUE-SAEKI M, SAEKI T, YAMAWAKI S, UCHITOMI Y: Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 43: 59-62, 2001.
8. KELLAR KL, IANNONE MA: Multiplexed microsphere-based flow cytometric assays. Exp Hematol 30: 1227-1237, 2002.
9. KATILA H, APPELBERG B, HURME M, RIMON R: Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res 12: 29-34, 1994.
10. LANQUILLON S, KRIEG JC, BENING-ABU-SHACH U, VEDDER H: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379, 2000.
11. MAES M, MELTZER HY, BOSMANS E, BERGMANS R, VANDOOLAEGHE E, RANJAN R, DESNYDER R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34: 301-309, 1995.
12. MAES M, SONG C, LIN AH, BONACCORSO S, KENIS G, DE JONGH R, BOSMANS E, SCHARPÉ S: Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20: 370-379, 1999.
13. MARQUES-DEAK AH, NETO FL, DOMINGUEZ WV, SOLIS AC, KURCGANT D, SATO F, ROSS JM, PRADO EB: Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res 41: 152-159, 2007.
14. MIKOVA O, YAKIMOVA R, BOSMANS E, KENIS G, MAES M: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11: 203-208, 2001.
15. MÜLLER N, SCHWARZ MJ: The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12: 988-1000, 2007.
16. O'BRIEN SM, SCULLY P, SCOTT LV, DINAN TG: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90: 263-267, 2006.
17. PENNINX BW, KRITCHEVSKY SB, YAFFE K, NEWMAN AB, SIMONSICK EM, RUBIN S, FERRUCCI L, HARRIS T, PAHOR M: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54: 566-572, 2003.
18. SLUZEWSKA A, RYBAKOWSKI J, LACIAK JK, MACKIEWICZ A, SOBIESKA M, WIKTOROWICZ K: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762: 474-476, 1995.
19. SLUZEWSKA A, RYBAKOWSKI J, BOSMANS E, SOBIESKA M, BERGHMANS R, MAES M, WIKTOROWICZ K: Indicators of immune activation in major depression. Psychiatry Res 64: 161-167, 1996.
20. SUTCIGIL L, OKTENLI C, MUSABAK U, BOZKURT A, CANSEVER A, UZUN O, SANISOGLU SY, YESILOVA Z, OZMENLER N, OZSAHIN A, SENGUL A: Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol: 76396, 2007.
21. THE WORLD HEALTH ORGANIZATION MONICA PROJECT (MONITORING TRENDS AND DETERMINANTS IN CARDIOVASCULAR DISEASE): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 41: 105-114, 1988.
22. ZUNG WWK: A self-rating depression scale. Arch Gen Psychiatry 12: 63-70, 1965.
23. ZUNG WWK: The role of rating scales in the identification and management of the depressed patient in the primary care setting. J Clin Psychiatry 51: 72-76, 1990.